Min Zhao

The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer

Xinyan Liu, Shucai Wu, Yonghui Yang et al. · Biomedicine & Pharmacotherapy · 2017 · 383 citations

Tumor Immunology, Cancer Immunosurveillance, Medicine +10

Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors

Hua Guo, Qingqing Ding, Yun Gong et al. · Breast Cancer Research · 2020 · 70 citations · Full text

Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma

Xiao Huang, Qingqing Ding, Hua Guo et al. · Human Pathology · 2020 · 40 citations

Breast Oncology, Cancer Detection, Medicine +9

MicroRNA‐410 promotes cell proliferation by targeting BRD7 in non‐small cell lung cancer

Dengrui Li, Yonghui Yang, Guiyun Zhu et al. · FEBS Letters · 2015 · 36 citations

Pathology, Mir-410 Acts, Cell Proliferation +17

Pediatric Cancer Pain Management Practices and Attitudes in China

Xin Shelley Wang, Jing Tang, Min Zhao et al. · Journal of Pain and Symptom Management · 2003 · 31 citations

Pain Therapy, Health Sciences, Pain Medicine +6